IBDEI14M ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20112,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20112,1,2,0)
 ;;=2^58340
 ;;^UTILITY(U,$J,358.3,20112,1,3,0)
 ;;=3^CATH FOR SIS OR HYSTEROSALPINGOGRAPHY
 ;;^UTILITY(U,$J,358.3,20113,0)
 ;;=58345^^113^1208^49^^^^1
 ;;^UTILITY(U,$J,358.3,20113,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20113,1,2,0)
 ;;=2^58345
 ;;^UTILITY(U,$J,358.3,20113,1,3,0)
 ;;=3^TRANSCERVICAL INTRO OF FALLOPIAN TUBE CATH
 ;;^UTILITY(U,$J,358.3,20114,0)
 ;;=J3420^^113^1209^1^^^^1
 ;;^UTILITY(U,$J,358.3,20114,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20114,1,2,0)
 ;;=2^J3420
 ;;^UTILITY(U,$J,358.3,20114,1,3,0)
 ;;=3^B12 INJ UP TO 1,000MCG
 ;;^UTILITY(U,$J,358.3,20115,0)
 ;;=J0800^^113^1209^2^^^^1
 ;;^UTILITY(U,$J,358.3,20115,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20115,1,2,0)
 ;;=2^J0800
 ;;^UTILITY(U,$J,358.3,20115,1,3,0)
 ;;=3^CORTISONE INJ UP TO 40U
 ;;^UTILITY(U,$J,358.3,20116,0)
 ;;=J9202^^113^1209^14^^^^1
 ;;^UTILITY(U,$J,358.3,20116,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20116,1,2,0)
 ;;=2^J9202
 ;;^UTILITY(U,$J,358.3,20116,1,3,0)
 ;;=3^ZOLADEX 3.6MG
 ;;^UTILITY(U,$J,358.3,20117,0)
 ;;=J1642^^113^1209^6^^^^1
 ;;^UTILITY(U,$J,358.3,20117,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20117,1,2,0)
 ;;=2^J1642
 ;;^UTILITY(U,$J,358.3,20117,1,3,0)
 ;;=3^HEP LOCK FLUSH PER 10U
 ;;^UTILITY(U,$J,358.3,20118,0)
 ;;=J7307^^113^1209^3^^^^1
 ;;^UTILITY(U,$J,358.3,20118,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20118,1,2,0)
 ;;=2^J7307
 ;;^UTILITY(U,$J,358.3,20118,1,3,0)
 ;;=3^ETONOGESTREL IMPLANT W/ SUPPLIES
 ;;^UTILITY(U,$J,358.3,20119,0)
 ;;=J1950^^113^1209^9^^^^1
 ;;^UTILITY(U,$J,358.3,20119,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20119,1,2,0)
 ;;=2^J1950
 ;;^UTILITY(U,$J,358.3,20119,1,3,0)
 ;;=3^LEUPROLIDE ACETATE 3.75MG
 ;;^UTILITY(U,$J,358.3,20120,0)
 ;;=J7302^^113^1209^10^^^^1
 ;;^UTILITY(U,$J,358.3,20120,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20120,1,2,0)
 ;;=2^J7302
 ;;^UTILITY(U,$J,358.3,20120,1,3,0)
 ;;=3^LEVONORGESTREL IU CONTRACEPT
 ;;^UTILITY(U,$J,358.3,20121,0)
 ;;=J1050^^113^1209^11^^^^1
 ;;^UTILITY(U,$J,358.3,20121,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20121,1,2,0)
 ;;=2^J1050
 ;;^UTILITY(U,$J,358.3,20121,1,3,0)
 ;;=3^MEDROXYPROGESTERONE 1MG
 ;;^UTILITY(U,$J,358.3,20122,0)
 ;;=90649^^113^1209^7^^^^1
 ;;^UTILITY(U,$J,358.3,20122,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20122,1,2,0)
 ;;=2^90649
 ;;^UTILITY(U,$J,358.3,20122,1,3,0)
 ;;=3^HPV VACCINE 3 DOSE
 ;;^UTILITY(U,$J,358.3,20123,0)
 ;;=90656^^113^1209^5^^^^1
 ;;^UTILITY(U,$J,358.3,20123,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20123,1,2,0)
 ;;=2^90656
 ;;^UTILITY(U,$J,358.3,20123,1,3,0)
 ;;=3^FLU,TRIVALENT,SPLIT,NO PRESERVATIVES
 ;;^UTILITY(U,$J,358.3,20124,0)
 ;;=90658^^113^1209^4^^^^1
 ;;^UTILITY(U,$J,358.3,20124,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20124,1,2,0)
 ;;=2^90658
 ;;^UTILITY(U,$J,358.3,20124,1,3,0)
 ;;=3^FLU VACCINE
 ;;^UTILITY(U,$J,358.3,20125,0)
 ;;=90732^^113^1209^12^^^^1
 ;;^UTILITY(U,$J,358.3,20125,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20125,1,2,0)
 ;;=2^90732
 ;;^UTILITY(U,$J,358.3,20125,1,3,0)
 ;;=3^PNEUMOCOCCAL VACCINE
 ;;^UTILITY(U,$J,358.3,20126,0)
 ;;=90715^^113^1209^13^^^^1
 ;;^UTILITY(U,$J,358.3,20126,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20126,1,2,0)
 ;;=2^90715
 ;;^UTILITY(U,$J,358.3,20126,1,3,0)
 ;;=3^TDAP VACCINE
 ;;^UTILITY(U,$J,358.3,20127,0)
 ;;=90686^^113^1209^8^^^^1
 ;;^UTILITY(U,$J,358.3,20127,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20127,1,2,0)
 ;;=2^90686
 ;;^UTILITY(U,$J,358.3,20127,1,3,0)
 ;;=3^INFLUENZA,QUADRIVALENT,PRESERV-FREE
